Loading clinical trials...
Loading clinical trials...
Discovering the Genetic Causes of Brugada Syndrome in Thais and Southeast Asian Population
Brugada syndrome (BrS) is the leading cause of sudden death in young Asian adults including Thailand. This syndrome may be hereditary and involve mutations in certain genes. Aim of the study is to identify the relationship between genetic variants and the diagnosis/clinical severity of patients with BrS.
This cohort study recruits BrS patients with confirmed Brugada type 1 ECG and healthy volunteers in Thailand. Data collection consists of demographic, clinical data, ECG and blood sample for genetic studies. Genotyping was done by whole genome sequencing and SNP array then compared between cases and controls. Each BrS patient will be followed up prospectively for symptoms and AICD shock. Subsequently, the study will analyze relationship between genetic variants and clinical data against clinical severity of BrS patients.
Age
All ages
Sex
ALL
Healthy Volunteers
Yes
Siriraj Hospital, Mahidol University
Bangkok Noi, Bangkok, Thailand
Vajira Hospital
Dusit, Bangkok, Thailand
Chulalongkorn University
Pathum Wan, Bangkok, Thailand
Faculty of Medicine Ramathibodi Hospital, Mahidol University
Ratchathewi, Bangkok, Thailand
Bhumibol Adulyadej RTAF Hospital
Sai Mai, Bangkok, Thailand
Bumrungrad International Hospital
Vadhana, Bangkok, Thailand
Pacific Rim Electrophysiology Research Institute Data Coordinating Center
Vadhana, Bangkok, Thailand
Bangkok Hospital
Bangkok, Thailand
Faculty of Medicine, Chiang Mai University
Chiang Mai, Thailand
Queen Sirikit Heart Center of the Northeast
Khon Kaen, Thailand
Start Date
January 28, 2016
Primary Completion Date
January 1, 2021
Completion Date
January 1, 2023
Last Updated
January 18, 2020
750
ESTIMATED participants
Lead Sponsor
Chulalongkorn University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions